HRS-4729 (KAI-4729) — Clinical data readout
2027
Kailera remains on track to begin a Phase 1 trial in 2026 with data anticipated in 2027.Source filing
KLRA biotech catalysts & pipeline
KAILERA THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
HRS-7535 (KAI-7535) — Clinical data readout
2027
The trial initiated in April 2026, with data expected in 2027.Source filing
ribupatide injection (KAI-9531) — Clinical data readout
mid-2027
Ribupatide injection Phase 2b high-dose trial in obesity fully enrolled, data anticipated in mid-2027Source filing
ribupatide injection (KAI-9531) — Clinical data readout
2028
Data are anticipated in 2028.Source filing